Managing Cancer Demands Flexibility and a Strategic Mindset
FDA Grants Full Approval to Vitrakvi For NTRK-Positive Solid Tumors
Kaifan Zhao, AGACNP-BC, PMHNP-BC, Wins CURE’s 2025 Extraordinary Healer® Award
First Patient Dosed in Trial of CT-95 in Mesothelin-Expressing Tumors